drugset / Trial / NCT02023606
Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M
NaSingle-groupOpen-labelTreatment
Summary
An Open-Label, Single-Dose, Mass-Balance Study to Assess the Absorption, Metabolism, and Excretion of Radio Labeled SPN-810M in Healthy Adult Male Volunteers
Timeline
- Start
- 2013-11
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPN-810M | Unknown | 50 mg | — |